Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Oral Bisphosphonate (MK-0822-076)
Status:
Terminated
Trial end date:
2014-11-11
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess to what extent sequential treatment with odanacatib
results in incremental gains in bone mineral density (BMD) over time in female participants
who have received at least 3 years of bisphosphonate therapy. It was hypothesized that
odanacatib treatment would increase femoral neck BMD relative to placebo after 24 months.